# Randomized Controlled Trial Comparing the Efficacy and Safety of FMT in Hepatitis B Reactivation Leads to Acute on Chronic Liver Failure.

> **NCT02689245** · NA · COMPLETED · sponsor: **Institute of Liver and Biliary Sciences, India** · enrollment: 64 (actual)

## Conditions studied

- Acute on Chronic Liver Failure

## Interventions

- **DRUG:** Tenofovir
- **DRUG:** Fecal Microbiota Transplantation (FMT)

## Key facts

- **NCT ID:** NCT02689245
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02-26
- **Primary completion:** 2018-03-13
- **Final completion:** 2018-03-13
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2018-11-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02689245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02689245, "Randomized Controlled Trial Comparing the Efficacy and Safety of FMT in Hepatitis B Reactivation Leads to Acute on Chronic Liver Failure.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02689245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*